Disease progression and survival in ALS: First multi‐state model approach

References

• Christensen P. B., Hojer‐Pedersen E., Jensen N. B. Survival of patients with amyotrophic lateral sclerosis in two Danish counties. Neurology 1990; 40: 600–4
   PubMed Web of Science ®Google Scholar
• Chancellor A. M., Slattery J. M., Fraser H., Swingler R. J., Holloway S. M., Warlow C. P. The prognosis of adult‐onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993; 240: 339–46
   PubMed Web of Science ®Google Scholar
• Tysnes O. B., Vollset S. E., Larsen J. P., Aarli J. A. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology 1994; 13: 226–35
   PubMed Web of Science ®Google Scholar
• Lee J. R., Annegers J. F., Appel S. H. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995; 132: 207–15
   PubMed Web of Science ®Google Scholar
• Preux P. M., Couratier P., Boutros‐Toni F., Salle J. Y., Tabaraud F., Bernet‐Bernady P., et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology 1996; 15: 153–60
   PubMed Web of Science ®Google Scholar
• Louwerse E. S., Visser C. E., Bossuyt P. M., Weverling G. J. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci 1997; 152((Suppl 1))S10–7
   PubMed Web of Science ®Google Scholar
• Thijs V., Peeters E., Theys P., Matthijs G., Robberecht W. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. Acta Neurol Belg 2000; 100: 84–90
   PubMed Web of Science ®Google Scholar
• Turner M. R., Bakker M., Sham P., Shaw C. E., Leigh P. N., Al‐Chalabi A. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3: 15–21
   PubMed Web of Science ®Google Scholar
• Chio A., Mora G., Leone M., Mazzini L., Cocito D., Giordana M. T., et al. Early symptom progression rate is related to ALS outcome: a prospective population‐based study. Neurology 2002; 59: 99–103
   PubMed Web of Science ®Google Scholar
• del Aguila M. A., Longstreth W. T., Jr., McGuire V., Koepsell T. D., van Belle G. Prognosis in amyotrophic lateral sclerosis: a population‐based study. Neurology 2003; 60: 813–9
   PubMed Web of Science ®Google Scholar
• Norris F., Shepherd R., Denys E, U. K. S., Mukai . E., Elias L., et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993; 118: 48–55
   PubMed Web of Science ®Google Scholar
• Eisen A., Schulzer M., MacNeil M., Pant B., Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993; 16: 27–32
   PubMed Web of Science ®Google Scholar
• Qureshi M. M., Hayden D., Urbinelli L., Ferrante K., Newhall K., Myers D., et al. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler 2006; 7: 173–82
   PubMed Web of Science ®Google Scholar
• Haverkamp L. J., Appel V., Appel S. H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707–19
   PubMed Web of Science ®Google Scholar
• Stambler N., Charatan M., Cedarbaum J. M. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998; 50: 66–72
   PubMed Web of Science ®Google Scholar
• Armon C., Graves M. C., Moses D., Forte D. K., Sepulveda L., Darby S. M., et al. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle Nerve 2000; 23: 874–82
   PubMed Web of Science ®Google Scholar
• Schiffman P. L., Belsh J. M. Pulmonary function at diagnosis of amyotrophic lateral sclerosis: rate of deterioration. Chest 1993; 103: 508–13
   PubMed Web of Science ®Google Scholar
• Kasarskis E. J., Berryman S., Vanderleest J. G., Schneider A. R., McClain C. J. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Cin Nutr 1996; 63: 130–7
   PubMed Web of Science ®Google Scholar
• Desport J. C., Preux P. M., Truong T. C., Vallat J. M., Sautereau D., Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999; 53: 1059–63
   PubMed Web of Science ®Google Scholar
• Brooks B. R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases /Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci 1994; 124((Suppl))96–107
   PubMed Web of Science ®Google Scholar
• Aid to the investigation of peripheral nerve injuries. War memorandum, 2nd edn, revised, Medical Research Council. His Majesty's Stationery Office, London 1943; 11–46
   Google Scholar
• Commenges D. Multi‐state models in epidemiology. Lifetime Data Anal 1999; 5: 315–27
   PubMed Web of Science ®Google Scholar
• Commenges D. Competitive risks and multi‐state models in epidemiology. (French) Rev Epidemiol Sante Publique 1999; 47: 605–11
   PubMed Web of Science ®Google Scholar
• Commenges D. Inference for multi‐state models from interval‐censored data. Stat Methods Med Res 2002; 11: 167–82
   PubMed Web of Science ®Google Scholar
• Joly P., Letenneur L., Alioum A., Commenges D., Joly P., Letenneur L., et al. PHMPL: a computer program for hazard estimation using a penalized likelihood method with interval‐censored and left‐truncated data. Comput Methods Programs Biomed 1999; 60: 225–31
   PubMed Web of Science ®Google Scholar
• Cox D. R. Regression models and life tables. Journal of the Royal Statistical Society, Series B 1972; 34: 187–220
   Web of Science ®Google Scholar
• Alioum A., Commenges D. MKVPCI: a computer program for Markov models with piecewise constant intensities and covariates. Comput Meth Progr Biomed 2001; 64: 109–19
   PubMed Web of Science ®Google Scholar
• Marshall G., Jones R. H. Multi‐state models and diabetic retinopathy. Stat Med 1995; 14: 1975–83
   PubMed Web of Science ®Google Scholar
• Young P. J., Weeden S., Kirwan J. R. The analysis of a bivariate multi‐state Markov transition model for rheumatoid arthritis with an incomplete disease history. Stat Med 1999; 18: 1677–90
   PubMed Web of Science ®Google Scholar
• Chevret S., Leporrier M., Chastang C. Measures of treatment effectiveness on tumour response and survival: a multi‐state model approach. Stat Med 2000; 19: 837–48
   PubMed Web of Science ®Google Scholar
• Boudemaghe T., Daures J. P. Modelling asthma evolution by a multi‐state model. (French) Rev Epidemiol Sante Publique 2000; 48: 249–55
   PubMed Web of Science ®Google Scholar
• Escolano S., Golmard J. L., Korinek A. M., Mallet A., Escolano S., Golmard J. L., et al. A multi‐state model for evolution of intensive care unit patients: prediction of nosocomial infections and deaths. Stat Med 2000; 19: 3465–82
   PubMed Web of Science ®Google Scholar
• Sypsa V., Touloumi G., Kenward M., Karafoulidou A., Hatzakis A. Comparison of smoothing techniques for CD4 data in a Markov model with states defined by CD4: an example on the estimation of the HIV incubation time distribution. Stat Med 2001; 20: 3667–76
   PubMed Web of Science ®Google Scholar
• Hsieh H. J., Chen T. H., Chang S. H. Assessing chronic disease progression using non‐homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan. Stat Med 2002; 21: 3369–82
   PubMed Web of Science ®Google Scholar
• Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585–91
   PubMed Web of Science ®Google Scholar
• Lyall R. A., Donaldson N., Polkey M. I., Leigh P. N., Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001; 124: 2000–13
   PubMed Web of Science ®Google Scholar
• Sorenson E. J., Stalker A. P., Kurland L. T., Windebank A. J. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002; 59: 280–2
   PubMed Web of Science ®Google Scholar
• Traynor B. J., Alexander M., Corr B., Frost E., Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry 2003; 74: 1258–61
   PubMed Web of Science ®Google Scholar
• Millul A., Beghi E., Logroscino G., Micheli A., Vitelli E., Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population‐based registry. Neuroepidemiology 2005; 25: 114–9
   PubMed Web of Science ®Google Scholar
• Munsat T. L., Andres P. L., Finison L., Conlon T., Thibodeau L. The natural history of motor neuron loss in amyotrophic lateral sclerosis. Neurology 1988; 38: 409–13
   PubMed Web of Science ®Google Scholar
• Magnus T., Beck M., Giess R., Puls I., Naumann M., Toyka K. V. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002; 25: 709–14
   PubMed Web of Science ®Google Scholar
• Ringel S. P., Murphy J. R., Alderson M. K., Bryan W., England J. D., Miller R. G., et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 43: 1316–22
   PubMed Web of Science ®Google Scholar
• Meininger V. Survival endpoint: summary. Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3((Suppl 1))S41–4
   Google Scholar
• Mitsumoto H., Davidson M., Moore D., Gad N., Brandis M., Ringel S., et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 177–85
   PubMed Web of Science ®Google Scholar